• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后的眼底自发荧光

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.

作者信息

Fujita Kyoko, Imamura Yutaka, Shinoda Kei, Matsumoto Soiti, Yuzawa Mitsuko

机构信息

Department of Ophthalmology, Aichi Medical University, Aichi, Japan.

Department of Ophthalmology, Teikyo University School of Medicine, University Hospital Mizonokuchi, Kanagawa, Japan.

出版信息

Biomed Hub. 2020 Dec 30;6(1):1-5. doi: 10.1159/000512662. eCollection 2021 Jan-Apr.

DOI:10.1159/000512662
PMID:33564669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7841749/
Abstract

INTRODUCTION

To evaluate the fundus autofluorescence (FAF) images 1 year after half-dose photodynamic therapy (hdPDT) for chronic central serous chorioretinopathy (CSC).

METHODS

Forty-six eyes of 46 consecutive patients with chronic CSC underwent hdPDT. Short wavelength-elicited FAF images and enhanced depth imaging optical coherence tomographic (EDI-OCT) images were recorded before and at 1, 3, 6, 9, and 12 months after the hdPDT. The FAF images at 1 month were compared to those at 12 months after the hdPDT.

RESULTS

The serous retinal detachment (SRD) was resolved in all eyes. The best-corrected visual acuity (BCVA) improved significantly from 0.13 ± 0.28 logarithm of minimum angle of resolution (logMAR) units before to 0.01 ± 0.17 logMAR units at 12 months after the hdPDT ( = 0.001; paired test). The mean choroidal thickness decreased significantly from 365.4 ± 103.0 µm to 284.3 ± 92.5 µm at 12 months ( < 0.001). Abnormal FAF images were present within the irradiated area in all the eyes before the hdPDT. In 5 of 46 eyes, identifiable changes of the FAF images were observed 12 months after hdPDT. None of the eyes had the confluent hypo-FAF type during the follow-up period. Univariate analyses showed that the choroidal thickness before hdPDT correlated significantly with hypo-FAF enlargement ( = 0.005). However, multivariate analyses showed that the association was not significant ( = 0.06).

CONCLUSIONS

The progression of the RPE damages occurred in approximately one-tenth of the eyes that underwent hdPDT for chronic CSC. The long-term effect of progression of hypo-FAF on visual functions remains to be determined.

摘要

引言

评估半剂量光动力疗法(hdPDT)治疗慢性中心性浆液性脉络膜视网膜病变(CSC)1年后的眼底自发荧光(FAF)图像。

方法

46例连续慢性CSC患者的46只眼接受了hdPDT治疗。在hdPDT治疗前以及治疗后1、3、6、9和12个月记录短波激发的FAF图像和增强深度成像光学相干断层扫描(EDI-OCT)图像。将hdPDT治疗后1个月的FAF图像与12个月后的图像进行比较。

结果

所有眼的浆液性视网膜脱离(SRD)均得到解决。最佳矫正视力(BCVA)从hdPDT治疗前的0.13±0.28最小分辨角对数(logMAR)单位显著提高至治疗后12个月的0.01±0.17 logMAR单位(P = 0.001;配对t检验)。12个月时脉络膜平均厚度从365.4±103.0 µm显著降至284.3±92.5 µm(P < 0.001)。hdPDT治疗前所有眼的照射区域内均存在异常FAF图像。46只眼中有5只在hdPDT治疗12个月后观察到FAF图像有可识别的变化。随访期间无眼出现融合性低自发荧光类型。单因素分析显示hdPDT治疗前的脉络膜厚度与低自发荧光扩大显著相关(P = 0.005)。然而,多因素分析显示该关联不显著(P = 0.06)。

结论

接受hdPDT治疗的慢性CSC患者中约十分之一的眼发生了视网膜色素上皮(RPE)损害进展。低自发荧光进展对视觉功能的长期影响仍有待确定。

相似文献

1
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后的眼底自发荧光
Biomed Hub. 2020 Dec 30;6(1):1-5. doi: 10.1159/000512662. eCollection 2021 Jan-Apr.
2
Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy.半剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变患者低亮度视力的改善
J Clin Med. 2020 Dec 9;9(12):3980. doi: 10.3390/jcm9123980.
3
Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy.比较微脉冲光凝与半剂量维替泊芬光动力疗法治疗中心性浆液性脉络膜视网膜病变的随机临床试验
Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):837-43. doi: 10.3928/23258160-20150909-08.
4
[Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy].[半剂量维替泊芬光动力疗法(hdPDT)治疗中心性浆液性脉络膜视网膜病变]
Klin Monbl Augenheilkd. 2016 Jul;233(7):860-3. doi: 10.1055/s-0041-106194. Epub 2015 Nov 26.
5
Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.急性中心性浆液性脉络膜视网膜病变:眼底自发荧光与光谱域光学相干断层扫描的相关性研究
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1889-97. doi: 10.1007/s00417-014-2899-5. Epub 2015 Jan 8.
6
One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量维替泊芬光动力疗法治疗一年的结果。
Ophthalmology. 2015 Mar;122(3):555-61. doi: 10.1016/j.ophtha.2014.09.034. Epub 2014 Nov 18.
7
Central serous chorioretinopathy fundus autofluorescence comparison with two different confocal scanning laser ophthalmoscopes.中心性浆液性脉络膜视网膜病变眼底自发荧光:两种不同共焦扫描激光眼底镜的比较
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2121-7. doi: 10.1007/s00417-015-2958-6. Epub 2015 Feb 18.
8
Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity.根据病程划分的中心性浆液性脉络膜视网膜病变的眼底自发荧光成像模式
Eye (Lond). 2016 Oct;30(10):1336-1342. doi: 10.1038/eye.2016.113. Epub 2016 Jun 10.
9
Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变中眼底自发荧光与中心视觉功能的相关性
Am J Ophthalmol. 2015 Apr;159(4):652-8. doi: 10.1016/j.ajo.2014.12.023. Epub 2014 Dec 30.
10
[Pathophysiology of macular diseases--morphology and function].黄斑疾病的病理生理学——形态与功能
Nippon Ganka Gakkai Zasshi. 2011 Mar;115(3):238-74; discussion 275.

本文引用的文献

1
Firth's logistic regression with rare events: accurate effect estimates and predictions?针对罕见事件的费思逻辑回归:准确的效应估计与预测?
Stat Med. 2017 Jun 30;36(14):2302-2317. doi: 10.1002/sim.7273. Epub 2017 Mar 12.
2
EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.使用扫频光学相干断层扫描对厚脉络膜疾病谱进行正面成像
Retina. 2016 Mar;36(3):499-516. doi: 10.1097/IAE.0000000000000742.
3
One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量维替泊芬光动力疗法治疗一年的结果。
Ophthalmology. 2015 Mar;122(3):555-61. doi: 10.1016/j.ophtha.2014.09.034. Epub 2014 Nov 18.
4
Pachychoroid neovasculopathy.厚脉络膜新生血管病变
Retina. 2015 Jan;35(1):1-9. doi: 10.1097/IAE.0000000000000331.
5
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者对侧眼的中心凹下脉络膜厚度。
Retina. 2011 Sep;31(8):1603-8. doi: 10.1097/IAE.0b013e31820f4b39.
6
Fundus autofluorescence and visual acuity in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的眼底自发荧光和视力。
Ophthalmology. 2011 Apr;118(4):700-5. doi: 10.1016/j.ophtha.2010.08.017. Epub 2010 Nov 5.
7
Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变脉络膜的增强深度成像光学相干断层扫描
Retina. 2009 Nov-Dec;29(10):1469-73. doi: 10.1097/IAE.0b013e3181be0a83.
8
Photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变的光动力疗法
Retina. 2003 Dec;23(6):752-63. doi: 10.1097/00006982-200312000-00002.
9
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.光动力疗法对人眼脉络膜和视网膜结构的剂量相关结构效应。
Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):748-57. doi: 10.1007/s00417-002-0517-4. Epub 2002 Aug 27.
10
Histopathological changes following photodynamic therapy in human eyes.人类眼睛光动力治疗后的组织病理学变化。
Arch Ophthalmol. 2002 Jun;120(6):835-44.